Another stock that's trading close to triggering a near-term breakout is Spectrum Pharmaceuticals (SPPI), a biotechnology company with integrated commercial and drug development operations with a focus in hematology and oncology. This stock has been trending lower so far in 2012, with shares off by over 16%.
If you look at the chart for Spectrum Pharmaceuticals, you'll see that the bears have destroyed this stock during the last two months following a double top chart pattern at around $17.48 to $17.19 a share. Shares of SPPI went on to plunge off that double top and recently hit a low of $11.13 a share. During that sharp move lower, shares of SPPI were consistently making lower highs and lower lows, which is bearish technical price action. That said, the stock has started to stabilize and trend sideways between $11.33 and $12.76 a share.
Traders should now look for long-biased trades in SPPI if it can manage to break out above some near-term overhead resistance at $12.75 to $12.76 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1.9 million shares. If that breakout triggers soon, then SPPI will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $14 to $14.50 a share. If SPPI can take out $14 to $14.50 a share, then it could easily trade north of $15 a share.One could look to buy SPPI off weakness and simply use a stop that sits just below some near-term support at $11.79 to $11.33 a share. You could also buy off strength once SPPI takes out $12.75 to $12.76 with volume, and then simply use a stop at around $11.80 a share. I would look to add to either position once SPPI clears $14 to $14.50 with heavy upside volume.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV